What problem does this paper attempt to address?

The problem that this paper attempts to solve is to develop a fluorescent drug sensor capable of rapidly detecting β - lactam antibiotics and non - β - lactam inhibitors. Specifically, through structural analysis, protein engineering and fluorescence labeling techniques, the researchers successfully constructed a fluorescent drug sensor (F70Cf) from the clinically relevant New Delhi metallo - β - lactamase - 1 (NDM - 1). This sensor can identify ineffective β - lactam antibiotics by exhibiting a characteristic fluorescence spectral pattern (the fluorescence signal is enhanced in the initial binding stage and then decreases due to the hydrolysis of β - lactam into acid products), and when combined with non - β - lactam inhibitors (such as L - captopril, D - captopril, DL - thiotephene and Thanatin), it shows a stronger and continuous fluorescence signal. ### Main objectives of the paper: 1. **Develop a fluorescent drug sensor**: By introducing cysteine at the phenylalanine residue at position 70 of NDM - 1 and labeling it with fluorescein - 5 - maleimide, a fluorescent drug sensor F70Cf was constructed. 2. **Detect β - lactam antibiotics**: F70Cf can detect β - lactam antibiotics (such as cefotaxime and cefalotin), and the binding and hydrolysis processes of antibiotics are reflected by the changes in fluorescence signals. 3. **Detect non - β - lactam inhibitors**: F70Cf can also detect non - β - lactam inhibitors (such as L - captopril, D - captopril, DL - thiotephene and Thanatin), and the binding of inhibitors is reflected by the continuous enhancement of fluorescence signals. 4. **High - throughput screening ability**: This sensor is compatible with high - throughput microplate readers, is suitable for in vitro drug screening, and improves screening efficiency. ### Problems solved: - **Antibiotic resistance**: With the abuse of β - lactam antibiotics, more and more bacteria produce β - lactamases, resulting in the ineffectiveness of antibiotics. This sensor can rapidly detect the effectiveness of antibiotics, which is helpful in fighting against resistant bacteria. - **Drug screening**: Traditional drug screening methods are time - consuming, while F70Cf can complete the detection within a few minutes, greatly improving the screening efficiency. - **Mechanism research**: Through molecular modeling and mass spectrometry analysis, the mechanism of F70Cf binding to different inhibitors was studied, providing a theoretical basis for the development of new inhibitors. ### Conclusion: This study successfully developed a fluorescent drug sensor F70Cf based on NDM - 1, which can rapidly detect β - lactam antibiotics and non - β - lactam inhibitors in vitro. This achievement not only helps in fighting against resistant bacteria, but also provides a powerful tool for drug screening and the development of new inhibitors.

Fluorescently Modified NDM-1: A Versatile Drug Sensor for Rapid In Vitro β-Lactam Antibiotic and Inhibitor Screening

Microbial Surface Displaying Formate Dehydrogenase and Its Application in Optical Detection of Formate.

The New Delhi metallo-β-lactamase-1 biosensor rapidly and accurately detected antibiotic plasma concentrations in cefuroxime-treated patients

Quantifying Membrane Alterations with Tailored Fluorescent Dyes: A Rapid Antibiotic Resistance Profiling Methodology

Rapid personalized AMR diagnostics using two-dimensional antibiotic resistance profiling strategy employing a thermometric NDM-1 biosensor

Real‐Time Monitoring of New Delhi Metallo‐β‐Lactamase Activity in Living Bacterial Cells by 1H NMR Spectroscopy

Mobile mini-fluorimeter for antibiotic aptasensing based on surface-plasmonic effect of burlike nanogolds enhanced by digitized imaging diagnosis

Inhibitor discovery of full-length New Delhi metallo-β-lactamase-1 (NDM-1).

Optimising CNT-FET biosensor design through modelling of biomolecular electrostatic gating and its application to β-lactamase detection

A simple design of fluorescent probes for indirect detection of β-lactamase based on AIE and ESIPT processes

Structure-based computational study of the hydrolysis of New Delhi metallo-β-lactmase-1

Multiple fluorescence response behaviors towards antibiotics and bacteria based on a highly stable Cd-MOF

Stereochemically altered cephalosporins as potent inhibitors of New Delhi metallo-β-lactamases

Pharmacophore-Based Study: An In Silico Perspective for the Identification of Potential New Delhi Metallo-β-lactamase-1 (NDM-1) Inhibitors

Fluorinated captopril analogues inhibit metallo-β-lactamases and facilitate structure determination of NDM-1 binding pose

A CRISPR/Cas12a-Based System for Sensitive Detection of Antimicrobial-Resistant Genes in Carbapenem-Resistant Enterobacterales

Aptasensor for multiplex detection of antibiotics based on FRET strategy combined with aptamer/graphene oxide complex

Activity fingerprinting of AMR β-lactamase towards a fast and accurate diagnosis

A molecularly imprinted nanocavity with transformable domains that fluorescently indicate the presence of antibiotics in meat extract samples

Innovative fluorescence sensing platform for β-lactams based on acidity/basicity-sensitive graphdiyne quantum dots

Strategic Design of Lysine-Targeted Irreversible Covalent NDM-1 Inhibitors